Vimedimex Medi – Pharma JSC (STC:VMD) EBITDA Margin %: 0.00% (As of . 20)


What is Vimedimex Medi – Pharma JSC EBITDA Margin %?

Vimedimex Medi – Pharma JSC STC:VMD EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vimedimex Medi – Pharma JSC's EBITDA for the three months ended in . 20 was ₫0.00 Mil. Vimedimex Medi – Pharma JSC's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, Vimedimex Medi – Pharma JSC's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Vimedimex Medi – Pharma JSC  (STC:VMD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Vimedimex Medi – Pharma JSC EBITDA Margin % Related Terms

Vimedimex Medi – Pharma JSC EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Vimedimex Medi – Pharma JSC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimedimex Medi – Pharma JSC EBITDA Margin % Chart

Vimedimex Medi – Pharma JSC Annual Data
Trend
EBITDA Margin %

Vimedimex Medi – Pharma JSC Quarterly Data
EBITDA Margin %

STC:VMD vs GOVX, MBVXQ, HSTC: EBITDA Margin % Comparison

For the Biotechnology subindustry, Vimedimex Medi – Pharma JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimedimex Medi – Pharma JSC EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vimedimex Medi – Pharma JSC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Vimedimex Medi – Pharma JSC's EBITDA Margin % falls into.


Vimedimex Medi – Pharma JSC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Vimedimex Medi – Pharma JSC's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Vimedimex Medi – Pharma JSC's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Vimedimex Medi – Pharma JSC (STC:VMD) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vimedimex Medi – Pharma JSC and its competitors.
Is Vimedimex Medi – Pharma JSC's EBITDA Margin % too high?
Vimedimex Medi – Pharma JSC's current EBITDA Margin % is 0.00%.
How does Vimedimex Medi – Pharma JSC's EBITDA Margin % compare to GOVX and MBVXQ?
Vimedimex Medi – Pharma JSC's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vimedimex Medi – Pharma JSC and its competitors. Vimedimex Medi – Pharma JSC's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimedimex Medi – Pharma JSC stock overvalued right now?
Vimedimex Medi – Pharma JSC (STC:VMD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vimedimex Medi – Pharma JSC (STC:VMD), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vimedimex Medi – Pharma JSC Business Description

Address 246 Cong Quynh Street, Pham Ngu Lao Ward, District 1, Ho Chi Minh City, VNM
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.